Albemarle shares rise 5.01% intraday after HSBC upgrades to Buy and BMO raises price target to $210.

Albemarle surged 5.01% intraday following an upgrade to Buy at HSBC, which highlighted its high sensitivity to lithium price increases, and an adjusted $210 price target from BMO Capital. These analyst actions signaled renewed confidence in the company’s exposure to rising lithium demand, aligning with the stock’s sharp intraday rally. Other news, such as a prior 3.6% gain or a 76% annual rise, did not directly correlate with the immediate intraday movement.